Long-term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome–positive leukemia resistant or intolerant to prior therapy

Jorge E. Cortes, Hagop M. Kantarjian, Michael J. Mauro, Fiona An, Sonja Nick, Eric Leip, Carlo Gambacorti-Passerini, Tim H. Brümmendorf

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome–positive leukemia resistant or intolerant to prior therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences